| RS1555475498 |
HEXA
|
Health Risk |
Likely pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555475519 |
HEXA
|
Health Risk |
Pathogenic |
Tay-Sachs disease, Tay-Sachs disease |
| RS1555475529 |
STUB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spinocerebellar ataxia 48, Spinocerebellar ataxia 48 |
| RS1555475794 |
STUB1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 16, Autosomal recessive spinocerebellar ataxia 16 |
| RS1555475961 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Brugada syndrome 8 |
| RS1555476935 |
CREBBP
|
Health Risk |
Likely pathogenic |
— |
| RS1555478015 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555478118 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555478331 |
CREBBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555478333 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555478582 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555478606 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555478654 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS1555479019 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Cardiovascular phenotype |
| RS1555479227 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555479341 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555479351 |
MPI
|
Health Risk |
Pathogenic/Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555479423 |
MPI
|
Health Risk |
Pathogenic/Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555479441 |
MPI
|
Health Risk |
Likely pathogenic |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1555481030 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555482611 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS1555482745 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1555482761 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555483682 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1555483689 |
CREBBP
|
Health Risk |
Pathogenic |
— |
| RS1555483699 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555483716 |
CREBBP
|
Health Risk |
Likely pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555483728 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555483834 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555484797 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555485607 |
SYNM
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNM-related disorder, SYNM-related disorder |
| RS1555485987 |
SYNM
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNM-related disorder, SYNM-related disorder |
| RS1555485994 |
SYNM
|
Health Risk |
Conflicting classifications of pathogenicity |
SYNM-related disorder, SYNM-related disorder |
| RS1555486021 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1555486560 |
GFER
|
Health Risk |
Pathogenic |
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome, Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome |
| RS1555486629 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS1555487316 |
UMOD
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1555487318 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1555487528 |
UMOD
|
Health Risk |
Pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, UMOD-related disorder |
| RS1555487621 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1555487726 |
UMOD
|
Health Risk |
Likely pathogenic |
— |
| RS1555487977 |
IFT140
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 80, Retinitis pigmentosa 80 |
| RS1555488069 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1555488093 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555488094 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555488119 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, See cases |
| RS1555488124 |
GRIN2A
|
Health Risk |
Likely pathogenic |
— |
| RS1555488144 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Self-limited epilepsy with centrotemporal spikes |
| RS1555488573 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1555488653 |
SETD1A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555489114 |
SCNN1B
|
Health Risk |
Likely pathogenic |
— |
| RS1555490554 |
SCNN1B
|
Health Risk |
Pathogenic |
— |
| RS1555491350 |
ROGDI
|
Health Risk |
Pathogenic |
Amelocerebrohypohidrotic syndrome, Amelocerebrohypohidrotic syndrome |
| RS1555491448 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS1555491453 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555491538 |
GRIN2A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, See cases |
| RS1555491648 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Self-limited epilepsy with centrotemporal spikes, Landau-Kleffner syndrome |
| RS1555491654 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Landau-Kleffner syndrome |
| RS1555492492 |
CHSY1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555492659 |
HSD3B7
|
Health Risk |
Pathogenic |
— |
| RS1555492758 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555492763 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555492766 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555492769 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555492790 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555492799 |
GRIN2A
|
Health Risk |
Pathogenic |
— |
| RS1555492819 |
NTHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS1555492932 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1555493029 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1555493585 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555493707 |
CNGB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1555493906 |
STX1B
|
Health Risk |
Likely pathogenic |
— |
| RS1555494222 |
STX1B
|
Health Risk |
Pathogenic |
Generalized epilepsy with febrile seizures plus, type 9 |
| RS1555494259 |
STX1B
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555494322 |
ABAT
|
Health Risk |
Pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS1555494671 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555494676 |
GRIN2A
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS1555494686 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555494699 |
GRIN2A
|
Health Risk |
Pathogenic |
Neoplasm, Landau-Kleffner syndrome |
| RS1555494781 |
GRIN2A
|
Health Risk |
Pathogenic |
— |
| RS1555495676 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1555495692 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1555495965 |
PMM2
|
Health Risk |
Pathogenic/Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS1555496051 |
PPIB
|
Health Risk |
Likely pathogenic |
— |
| RS1555496083 |
SLC5A2
|
Health Risk |
Pathogenic |
Familial renal glucosuria, Familial renal glucosuria |
| RS1555496111 |
GRIN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Self-limited epilepsy with centrotemporal spikes, Landau-Kleffner syndrome |
| RS1555496202 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1555496560 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to CREBBP mutations, Rubinstein-Taybi syndrome due to CREBBP mutations |
| RS1555496581 |
CREBBP
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome, Rubinstein-Taybi syndrome |
| RS1555496732 |
CREBBP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555496968 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1555497029 |
COG4
|
Health Risk |
Pathogenic |
— |
| RS1555497542 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1555497568 |
COG7
|
Health Risk |
Pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1555497604 |
COG7
|
Health Risk |
Likely pathogenic |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS1555497641 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1555497690 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1555497714 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1555497891 |
KATNIP
|
Health Risk |
Pathogenic |
Joubert syndrome 26, Joubert syndrome 26 |
| RS1555498092 |
USB1
|
Health Risk |
Pathogenic |
Poikiloderma with neutropenia, Poikiloderma with neutropenia |